Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication October 6, 2017
- Accepted for publication November 26, 2017
- Published online May 1, 2018.
Article Versions
- previous version (December 14, 2017 - 09:27).
- previous version (December 21, 2017 - 08:24).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- 1Department of Molecular and Medical Pharmacology, Ahmanson Translational Imaging Division, University of California at Los Angeles, Los Angeles, California; and
- 2Department of Nuclear Medicine, Universitätsklinikum Essen, Essen, Germany
- For correspondence or reprints contact: Jeremie Calais, Ahmanson Translational Imaging Division, UCLA Nuclear Medicine Department, 200 Medical Plaza, Suite B114, Los Angeles, CA 90095. E-mail: jcalais{at}mednet.ucla.edu
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- 18F-DCFPyL PET Acquisition, Interpretation, and Reporting: Suggestions After Food and Drug Administration Approval
- Disparities in PET Imaging for Prostate Cancer at a Tertiary Academic Medical Center
- Head-to-Head Comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard
- Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management
- Best Practices for 18F-Fluciclovine PET/CT Imaging of Recurrent Prostate Cancer: A Guide for Technologists
- One-Step 18F-Labeling and Preclinical Evaluation of Prostate-Specific Membrane Antigen Trifluoroborate Probes for Cancer Imaging
- Molecular Imaging of Prostate Cancer: Choosing the Right Agent
- Reply: Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its Way
- Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Interesting, but Far from Definitive